About Amprion
Amprion is a company based in Houston (United States) founded in 2006. It operates as a HealthTech. Amprion has raised $11.76 million across 9 funding rounds from investors including Lilly, HHS and Foundry. Amprion offers products and services including SAAmplify-αSYN. Amprion operates in a competitive market with competitors including ADx NeuroSciences, Cytox, PeopleBio R&D, Durin Technologies and ALA Diagnostics, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Amprion Diagnostics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.76 M (USD)
in 9 rounds
-
Latest Funding Round
Not available
-
Investors
Lilly
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amprion
Amprion offers a comprehensive portfolio of products and services, including SAAmplify-αSYN.
A test detecting pathological α-synuclein in CSF samples.
People of Amprion
Unlock access to complete
Funding Insights of Amprion
Amprion has successfully raised a total of $11.76M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Amprion
Amprion has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Lilly, HHS and Foundry.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Scientists are empowered to reduce human suffering through capital and company-building expertise provided by the firm.
|
Locked | Locked | Locked | |
|
Traditional pharmaceutical medicines are developed for multiple health fields.
|
Locked | Locked | Locked |
Investor details for Amprion
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amprion
Investment portfolio details for Amprion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Amprion
Detailed financials for Amprion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amprion Comparisons
Peer comparison for Amprion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amprion
Amprion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ADx NeuroSciences, Cytox, PeopleBio R&D, Durin Technologies and ALA Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
|
|
| Locked | Locked | Locked |
Prognostic tests for assessing dementia risk are developed.
|
|
| Locked | Locked | Locked |
Immunoassays are developed for early detection of neurodegenerative diseases.
|
|
| Locked | Locked | Locked |
Developer of the diagnostic test for neurodegenerative diseases
|
|
| Locked | Locked | Locked |
In vitro diagnostic kits for multiple sclerosis detection are developed.
|
Detailed competitors of Amprion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amprion
Complete news archive for Amprion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amprion
Amprion was founded in 2006 and raised its 1st funding round 6 years after it was founded.
Amprion is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Amprion is a funded company, having raised a total of $11.76M across 9 funding rounds to date.
Amprion Diagnostics is engaged in developing diagnostic tests for neurodegenerative disorders such as Parkinsons, Lewy body dementia, and Alzheimers. The companys primary offering, SAAmplify-αSYN, is a validated test for detecting pathological α-synuclein in cerebrospinal fluid, providing biological clarity with autopsy-confirmed accuracy. Services are tailored for patients, clinicians, and biopharma partners to improve diagnosis and treatment decisions. Research partnerships are maintained to advance insights into disease biology across healthcare sectors.
Amprion's top competitors include ADx NeuroSciences, PeopleBio R&D and Cytox.
Amprion offers SAAmplify-αSYN.